DONEY JAIN: Open Payments
NPI 1720484777 · JERSEY CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 9 payments from 8 companies in 2025. Trend: 2023 $348 · 2024 $513 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| Kerecis Limited | 2 | $193 |
| Exact Sciences Corporation | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Braeburn Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: Kerecis SurgiClose, Cologuard Collection Kit, AUSTEDO XR, ABILIFY ASIMTUFII, Auvelity, BRIXADI, REXULTI, INGREZZA.
Industry payments across NJ — which companies pay providers there.
